We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.21B
AUM Growth
+$1.17B
Cap. Flow
+$1.31B
Cap. Flow %
15.93%
Top 10 Hldgs %
19.59%
Holding
1,801
New
278
Increased
701
Reduced
627
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Financials 9.29%
3 Industrials 9.2%
4 Healthcare 6.57%
5 Communication Services 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
801
BorgWarner
BWA
$13.2B
$1.17M 0.01%
+21,599
New +$1.14M
WSM icon
802
Williams-Sonoma
WSM
$26.7B
$1.17M 0.01%
6,397
+27
+0.4% +$5.39K
XMMO icon
803
Invesco S&P MidCap Momentum ETF
XMMO
$7.39B
$1.15M 0.01%
7,910
-3,935
-33% -$569K
STEW
804
SRH Total Return Fund
STEW
$1.75B
$1.14M 0.01%
66,933
-1,165
-2% -$20.7K
ILCV icon
805
iShares Morningstar Value ETF
ILCV
$1.3B
$1.14M 0.01%
+12,261
New +$1.17M
DON icon
806
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$1.14M 0.01%
21,697
-5,208
-19% -$281K
PCEF icon
807
Invesco CEF Income Composite ETF
PCEF
$812M
$1.14M 0.01%
60,551
-7,078
-10% -$140K
WAT icon
808
Waters Corp
WAT
$36.8B
$1.14M 0.01%
3,820
+1,004
+36% +$344K
FTXN icon
809
First Trust Nasdaq Oil & Gas ETF
FTXN
$175M
$1.14M 0.01%
+29,426
New +$980K
BWXT icon
810
BWX Technologies
BWXT
$16B
$1.14M 0.01%
5,554
+1,407
+34% +$286K
STRL icon
811
Sterling Infrastructure
STRL
$20.3B
$1.13M 0.01%
2,779
-790
-22% -$309K
WST icon
812
West Pharmaceutical
WST
$23.1B
$1.13M 0.01%
4,514
+20
+0.4% +$4.98K
QQQI icon
813
NEOS Nasdaq 100 High Income ETF
QQQI
$12.6B
$1.13M 0.01%
22,731
+5,826
+34% +$307K
LYB icon
814
LyondellBasell Industries
LYB
$19.5B
$1.12M 0.01%
13,960
+6,025
+76% +$357K
IWN icon
815
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.12M 0.01%
5,928
+471
+9% +$91.2K
TEI
816
Templeton Emerging Markets Income Fund
TEI
$310M
$1.12M 0.01%
186,688
+5,246
+3% +$34.6K
ILCG icon
817
iShares Morningstar Growth ETF
ILCG
$3.1B
$1.12M 0.01%
11,730
+9,384
+400% +$953K
IBDV icon
818
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.25B
$1.12M 0.01%
51,103
-2,590
-5% -$57.1K
UHS icon
819
Universal Health Services
UHS
$9.43B
$1.11M 0.01%
+6,224
New +$1.28M
WPC icon
820
W.P. Carey
WPC
$17.1B
$1.11M 0.01%
16,339
-52
-0.3% -$3.65K
PAYC icon
821
Paycom
PAYC
$6.78B
$1.11M 0.01%
9,107
+3,686
+68% +$493K
TTMI icon
822
TTM Technologies
TTMI
$13.6B
$1.11M 0.01%
11,350
-4,018
-26% -$382K
IBDU icon
823
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.01B
$1.1M 0.01%
+47,351
New +$1.11M
XLRE icon
824
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
$1.1M 0.01%
26,851
+768
+3% +$32.2K
RWM icon
825
ProShares Short Russell2000
RWM
$122M
$1.09M 0.01%
+67,461
New +$1.06M

Similar funds

Oppenheimer & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Oppenheimer & Co held 1,801 positions worth $8.21B, up 17% from $7.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co deployed $1.31B of net new capital in Q1 2026, opening 278 new positions and adding to 701 existing holdings. Its largest new stake was Apple: 1,107,179 shares worth $281M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $11.2M trimmed.

  • Oppenheimer & Co's largest Q1 2026 buy was Apple: 1,107,179 shares worth $281M.
  • Oppenheimer & Co added most to Microsoft in Q1 2026, an estimated $24M increase.
  • Oppenheimer & Co's biggest Q1 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $11.2M.
  • Oppenheimer & Co fully exited Telefonica in Q1 2026, selling an estimated $6.36M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $8.21B portfolio in Q1 2026.
  • Oppenheimer & Co opened 278 new positions and closed 118 in Q1 2026.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $8.21B.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.